These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 24098563)

  • 1. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.
    Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ
    PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against
    Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
    [No Abstract]   [Full Text] [Related]  

  • 3. Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis.
    Tiyawisutsri R; Holden MT; Tumapa S; Rengpipat S; Clarke SR; Foster SJ; Nierman WC; Day NP; Peacock SJ
    BMC Microbiol; 2007 Mar; 7():19. PubMed ID: 17362501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the common marmoset to study Burkholderia mallei infection.
    Jelesijevic T; Zimmerman SM; Harvey SB; Mead DG; Shaffer TL; Estes DM; Michel F; Quinn FD; Hogan RJ; Lafontaine ER
    PLoS One; 2015; 10(4):e0124181. PubMed ID: 25860021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
    Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
    PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
    Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
    Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Burkholderia mallei and pseudomallei vaccines.
    Silva EB; Dow SW
    Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct human antibody response to the biological warfare agent Burkholderia mallei.
    Varga JJ; Vigil A; DeShazer D; Waag DM; Felgner P; Goldberg JB
    Virulence; 2012 Oct; 3(6):510-4. PubMed ID: 23076276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
    Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines].
    Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA
    Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei.
    Waag DM; Chance TB; Trevino SR; Rossi FD; Fetterer DP; Amemiya K; Dankmeyer JL; Ingavale SS; Tobery SA; Zeng X; Kern SJ; Worsham PL; Cote CK; Welkos SL
    Microb Pathog; 2021 Jun; 155():104919. PubMed ID: 33915206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?
    Titball RW; Burtnick MN; Bancroft GJ; Brett P
    Vaccine; 2017 Oct; 35(44):5981-5989. PubMed ID: 28336210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.
    Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ
    Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.
    Aschenbroich SA; Lafontaine ER; Hogan RJ
    Expert Rev Vaccines; 2016 Sep; 15(9):1163-81. PubMed ID: 27010618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice.
    Bearss JJ; Hunter M; Dankmeyer JL; Fritts KA; Klimko CP; Weaver CH; Shoe JL; Quirk AV; Toothman RG; Webster WM; Fetterer DP; Bozue JA; Worsham PL; Welkos SL; Amemiya K; Cote CK
    PLoS One; 2017; 12(2):e0172627. PubMed ID: 28235018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
    Galyov EE; Brett PJ; DeShazer D
    Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection from pneumonic infection with burkholderia species by inhalational immunotherapy.
    Goodyear A; Kellihan L; Bielefeldt-Ohmann H; Troyer R; Propst K; Dow S
    Infect Immun; 2009 Apr; 77(4):1579-88. PubMed ID: 19179415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkholderia vaccines: are we moving forward?
    Choh LC; Ong GH; Vellasamy KM; Kalaiselvam K; Kang WT; Al-Maleki AR; Mariappan V; Vadivelu J
    Front Cell Infect Microbiol; 2013; 3():5. PubMed ID: 23386999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice.
    Bernhards RC; Cote CK; Amemiya K; Waag DM; Klimko CP; Worsham PL; Welkos SL
    Arch Microbiol; 2017 Mar; 199(2):277-301. PubMed ID: 27738703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increase in intracellular p62/NBR1 and persistence of Burkholderia mallei and B. pseudomallei in infected mice linked to autophagy deficiency.
    Saikh KU; Dankmeyer JL; Zeng X; Ulrich RG; Amemiya K
    Immun Inflamm Dis; 2019 Mar; 7(1):7-21. PubMed ID: 30569531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.